A bias against selection of recent or chronically activated CD8+ T cells by multimers may grossly underestimate the degree of CD8+ T cell activation in disease, and could confound recent findings in diseases such as type 1 diabetes (24). This evidence concerns the gene CD8A and type 1 diabetes mellitus.